Article Text
Scientific letters
Right ventricular reverse remodelling after sildenafil in pulmonary arterial hypertension
Statistics from Altmetric.com
Footnotes
-
The study was funded by the Department of Pulmonary Diseases, VU University Medical Center and the Institute for Cardiovascular Research, VU University Medical Center. Sildenafil was provided by Pfizer Inc. Pfizer Inc had no involvement in study design, in the collection, analysis and interpretation of data, in the writing of the report or in the decision to submit the paper for publication.
-
Competing interests: None declared.